About Ipsen US

Who We Are

Ipsen US is comprised of both Ipsen Biopharmaceuticals, Inc. and Ipsen Bioscience, Inc. At Ipsen, we have a clear mission: to improve patients’ lives. We are a dynamic and growing global biopharmaceutical leader focused on innovation and specialty care, with a focus on 3 core areas: oncology, neuroscience, and rare diseases.

The patients we serve live with serious and rare diseases, and we pride ourselves on putting these patients first. It’s this approach to our daily work that has led Ipsen to make the bold ambition of launching at least 1 new product or meaningful indication each year.

To keep this ambition, we work with a sense of urgency and the agility of a biotech—leveraging our global reach—to bring innovative products to the patients who need them most.

Who We Are


To fuel and accelerate our rapid growth, we have expanded our presence in the leading biotech ecosystem and established our North American headquarters in Cambridge, Massachusetts, where we have a global hub and a fully integrated biopharmaceutical team collaborating across US and global commercial operations, Global External Innovation and Partnering, R&D, and manufacturing.

We have strategically expanded our footprint in Cambridge so we can be in the heart of the leading global biotech ecosystem.

Our Cambridge Leadership Team

Richard Paulson, Executive Vice President and CEO of Ipsen North America

Ivana Magovčević-Liebisch, PhD, JD, Executive Vice President and Chief Business Officer

Howard Mayer, MD, Executive Vice President, R&D, and Chief Scientific Officer

John Kehoe, Vice President, Ipsen Cambridge Manufacturing, US

Read more about the strong international experience of Ipsen’s global leadership team.


Our People

Our people—the foundation on which we achieve the Ipsen Group’s mission and success—are driven by a passion to win for patients and bring this mission to life every day. We are always ready to listen to—and learn from—patients. Every day, our more than 5,400 employees worldwide, approximately 600 of whom are in North America, work diligently with the singular purpose of developing and commercializing innovative medicines to improve the lives of patients around the world with difficult-to-treat diseases.

Our People


North American Fact Sheet and Company Background


Annual Report



Any statements contained in this website that do not describe historical facts are forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially. Ipsen cautions users not to place undue reliance on any forward-looking statements. Ipsen disclaims any obligation to publicly update or revise any such statements to reflect any changes on which any such statements may be based, or that may affect the likelihood that actual results will differ from those set forth in the forward-looking statements.

© Ipsen Biopharmaceuticals, Inc. 2019